Net Revenues (Tables)

12 Months Ended

Dec. 31, 2025

Schedule of distribution of net consolidated revenues by segment


		Millions of Euros
		2025		2024		2023
Biopharma		6,487		6,143		5,558
Diagnostic		640		645		670
Bio supplies		154		216		160
Others		243		208		204
Net sales		7,524		7,212		6,592

Schedule of geographical distribution of net consolidated revenues


		Millions of Euros
		2025		2024		2023
USA and Canada		4,253		4,087		3,899
Spain		418		423		363
European Union		1,196		1,076		893
Rest of the world		1,657		1,626		1,437
Net sales		7,524		7,212		6,592

Schedule of discounts and other reductions in gross income


		Millions of Euros
		2025		2024		2023
Gross sales		10,603		9,490		8,389
Chargebacks		(2,524)		(1,892)		(1,525)
Cash discounts		(115)		(93)		(82)
Volume rebates		(60)		(76)		(59)
Medicare and Medicaid		(182)		(72)		(68)
Other discounts		(197)		(144)		(63)
Net sales		7,524		7,212		6,592

Schedule of movement in discounts and other reductions in gross income


		Millions of Euros
								Medicare /		Other
		Chargebacks		Cash discounts		Volume rebates		Medicaid		discounts		Total
Balance at 31 December 2024		386		7		41		25		102		561
Current estimate related to sales made in current and previous periods (1)		2,524		115		60		182		197		3,078
(Actual returns or credits in current period related to sales made in current and previous periods) (2)		(2,391)		(106)		(73)		(133)		(178)		(2,881)
Translation differences		(51)		(5)		(6)		(5)		(2)		(69)
Balance at 31 December 2025		468		11		22		69		119		689

(1)

Net impact in the Consolidated Statements of Profit and Loss: estimate for the current year plus prior years’ adjustments. Adjustments made during the year corresponding to prior years’ estimates have not been significant.

(2)

Amounts credited and posted against provisions for current and previous periods.


		Millions of Euros
								Medicare /		Other
		Chargebacks		Cash discounts		Volume rebates		Medicaid		discounts		Total
Balance at 31 December 2023		318		7		24		26		35		410
Current estimate related to sales made in current and previous periods (1)		1,892		93		76		72		144		2,277
(Actual returns or credits in current period related to sales made in current and previous periods) (2)		(1,842)		(92)		(61)		(75)		(77)		(2,147)
Translation differences		18		(1)		2		2		—		21
Balance at 31 December 2024		386		7		41		25		102		561


		Millions of Euros
								Medicare /		Other
		Chargebacks		Cash discounts		Volume rebates		Medicaid		discounts		Total
Balance at 31 December 2022		264		6		24		27		26		347
Current estimate related to sales made in current and previous periods (1)		1,525		82		59		68		63		1,797
(Actual returns or credits in current period related to sales made in current and previous periods) (2)		(1,460)		(81)		(58)		(68)		(54)		(1,721)
Translation differences		(11)		—		(1)		(1)		—		(13)
Balance at 31 December 2023		318		7		24		26		35		410